Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs 510 crore) from its distribution centres in the US, Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on Monday.

CEO Albert Bourla stated that, ‘We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India’.

We are committed to being a partner in India’s fight against this disease and are quickly working to mobilize the largest humanitarian relief effort in our company’s history, later he added.

Right now, Pfizer colleagues at distribution centres in the US, Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its COVID-19 treatment protocol.

These medicines, valued at more than USD 70 million, will be made available immediately and ‘we will work closely with the government and our NGO partners to get them to where they are needed most,’ he added.